Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 3;2021(1):hoab006.
doi: 10.1093/hropen/hoab006. eCollection 2021.

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI

Frank Broekmans  1 , Peter Humaidan  2 , George Lainas  3 , Mira Töyli  4 , Nathalie Le Clef  5 , Nathalie Vermeulen  5
Affiliations
Comment

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI

Frank Broekmans et al. Hum Reprod Open. .
No abstract available

PubMed Disclaimer

Comment on

  • ESHRE guideline: ovarian stimulation for IVF/ICSI†.
    Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. Ovarian Stimulation TEGGO, et al. Hum Reprod Open. 2020 May 1;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009. eCollection 2020. Hum Reprod Open. 2020. PMID: 32395637 Free PMC article.

References

    1. Tournaye H, Sukhikh GT, Kahler E, Griesinger G.. A phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod (Oxford, Engl) 2017;32:1019–1027. - PMC - PubMed
    1. Griesinger G, Blockeel C, Sukhikh GT, Patki A, Dhorepatil B, Yang DZ, Chen ZJ, Kahler E, Pexman-Fieth C, Tournaye H.. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod (Oxford, Engl) 2018;33:2212–2221. - PMC - PubMed
    1. Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol 2012;28:983–990. - PMC - PubMed
    1. Nadarajah R, Rajesh H, Wong KY, Faisal F, Yu SL.. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques. Singapore MedJ 2017;58:294–297. - PMC - PubMed
    1. Saccone G, Schoen C, Franasiak JM, Scott RT Jr., Berghella V.. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril 2017;107:430–438.e433. - PubMed

LinkOut - more resources